Business
Agreement with MD Anderson for Phase 1B CHM 0201 AML study
Agreement with MD Anderson for Phase 1B CHM 0201 AML study
About this update from Chimeric Therapeutics Limited
[{"type":"text","content":"Chimeric Therapeutics Ltd has released a press release. View Attachment","length":253,"tagName":"div"}]